Sumitomo Pharma reports a drop in core profit in the second quarter despite sales growth.
Sumitomo Pharma reports a drop in core profit in the second quarter despite sales growth.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in